EG-1 interacts with c-Src and activates its signaling pathway

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 1013-1018

  Lu, Ming ^a   Liping, Zhang ^a   Sartippour, Maryam R ^a   Norris, Andrew J ^a   Brooks, Mai N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; EG 1; Magicin; Med28; SH3; Src; WW domain

Indexed keywords

EG1 PROTEIN, HUMAN; PROTEIN; PROTEIN KINASE P60;

ARTICLE; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; TRANSACTIVATION; TUMOR CELL LINE;

CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; NEOPLASMS; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANS-ACTIVATION (GENETICS);

EID: 39049180409     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.1013     Document Type: Article

References (19)

1. Wood WC, Muss HB, Solin LJ and Olopade OI: Malignant tumors of the breast. In: Cancer: Principles and Practice of Oncology. De Vita VT, Hellman S and Rosenberg SA (eds). Lippincott-Raven, Philadelphia, pp1415-1477, 2005.
2. Liu C, Zhang L, Beatty P, Sartippour M, Lane T, Barsky SH, Livingston E and Nguyen M: Identification of a novel endothelial-derived gene. Biochem Biophys Res Commun 290: 602-612, 2002.
3. Zhang L, Maul RS, Rao J, Apple S, Seligson D, Sartippour M, Rubio R and Brooks MN: Expression pattern of the novel gene EG-1 in cancer. Clin Cancer Res 10: 3504-3508, 2004.
4. Lu M, Zhang L, Maul RS, Sartippour MR, Norris A, Whitelegge J, Rao J and Brooks MN: The novel gene EG-1 stimulates cellular proliferation. Cancer Res 65: 6159-6166, 2005.
5. Pawson T: Protein modules and signalling networks. Nature 373: 573-580, 1995.
6. Macias MJ, Wiesner S and Sudol M: WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett 513: 30-37, 2002. (Pubitemid 34242975)
7. Silva CM: Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23: 8017-8023, 2004.
8. Parsons SJ and Parsons JT: Src family kinases, key regulators of signal transduction. Oncogene 23: 7906-7909, 2004.
9. Ishizawar RC, Tice DA, Karaoli T and Parsons SJ: The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism. J Biol Chem 279: 23773-23781, 2004.
10. Bromann PA, Korkaya H and Courtneidge SA: The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23: 7957-7968, 2004. (Pubitemid 39468854)
11. Yeatman TJ: A renaissance for src. Nature Rev 4: 470-480, 2004.
12. Akhand AA, Pu M, Senga T, Kato M, Suzuki H, Miyata T, Hamaguchi M and Nakashima I: Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J Biol Chem 274: 25821-25826, 1999.
13. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, Iyengar R and Klotman PE: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651, 2004.
14. Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002.
15. Wiederhold T, Lee MF, James M, Neujahr R, Smith N, Murthy A, Hartwig J, Gusella JF and Ramesh V: Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2. Oncogene 23: 8815-8825, 2004. (Pubitemid 39593296)
16. Schlessinger J: Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306: 1506-1507, 2004.
17. Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, Banks CAS, Jin J, Cai Y, Washburn MP, Conaway JW and Conaway RC: A set of consensus mammalian mediator subunits identified by multidimentional protein identification technology. Mol Cell 14: 685-691, 2004.
18. Conaway JW, Florens L, Sato S, Tomomori-Sato C, Parmely TJ, Yao T, Swanson SK, Banks CAS, Washburn MP and Conaway RC: The mammalian Mediator comples. FEBS Lett 579: 904-908, 2005.
19. Kharas MG and Fruman DA: ABL oncogenes and phosphoinositide-3-kinase: Mechanism of activation and downstream effectors. Cancer Res 65: 2047-2053, 2005.